Data as of Nov 26
| -0.07 / -1.64%|
The 1 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +233.33% increase from the last price of 4.20.
The current consensus among 1 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.